Caleb DesRosiers - 15 Jul 2024 Form 4 Insider Report for DAXOR CORP (DXR)

Role
Director
Signature
/s/ Caleb DesRosiers
Issuer symbol
DXR
Transactions as of
15 Jul 2024
Transactions value $
$0
Form type
4
Filing time
17 Jul 2024, 18:01:31 UTC
Previous filing
13 Jul 2023
Next filing
26 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DXR Stock options (right to buy) Award $0 +2,500 $0 2,500 15 Jul 2024 Common Stock 2,500 $9.2 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options granted on July 11, 2022 are contingent on the approval of the Securities & Exchange Commission ("SEC") to amend the Daxor Corporation 2020 Incentive Compensation Plan (the "Plan")
F2 The stock options will vest in three (3) installments - July 15, 2024 (833); July 15, 2025 (833); July 15, 2026 (834)